BIO vs JHG · rev $651.0M vs P/E 16, rev $3.10B
BIO (BIO) versus Janus Henderson Group PLC (JHG) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Janus Henderson Group PLC (JHG) is a asset management company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported JHG revenue for 2025-12-31 was $3.10B. Net income was $815.9M. Revenue was up 25.2% from 2024-12-31 to 2025-12-31. JHG currently screens at market cap $6.50B and trailing P/E 16.4.
BIO currently screens at market cap $0. JHG currently screens at market cap $6.50B and trailing P/E 16.4.
Not investment advice. Open the BIO and JHG stock pages for the full models.
Not investment advice.